From Maritza Perez - Drug Policy Alliance <[email protected]>
Subject Help secure historic overdose prevention funding in Congress
Date September 15, 2021 5:05 PM
  Links have been removed from this email. Learn more in the FAQ.
  Links have been removed from this email. Learn more in the FAQ.
Friend,

As you know, the overdose crisis is raging. Last year, drug overdose deaths in the U.S. increased by more than 30%, killing close to 100,000 people — the highest number ever on record.

The U.S. House of Representatives took an important step toward overdose prevention by passing an FY22 spending bill that included historic and critical funding for syringe services programs. 

Now it’s time to convince the Senate — which is considering its spending bills now  — to do the same. Urge your Senators to include funding for syringe services programs in its FY22 appropriations bill.

==========
TAKE ACTION: [link removed]
========== 

Syringe services and harm reduction programs are proven to prevent overdose deaths and also connect people to medical care and support, including substance use disorder treatment.

However, many of these essential services have experienced or expect budget cuts as a result of the COVID-19 pandemic. 

Congress can and must act now to save lives: tell your Senators to fund syringe services programs.

==========
TAKE ACTION: [link removed]
==========

To curb the overdose crisis, drug use must be treated as a health issue instead of a crime. With your support, let’s make sure Congress takes a step in that direction by investing in life-saving overdose prevention and syringe services programs.

Sincerely,

Maritza Perez
Director, National Affairs
Drug Policy Alliance


Take Action: [link removed] [link removed] [link removed]

The Drug Policy Alliance depends entirely on private donations to fund our work to end the war on drugs and promote new drug policies grounded in science, compassion, health, and human rights. Your support is crucial – thank you!

Donate: [link removed]

You have received this email because [email protected] is a member of the Drug
Policy Alliance mailing list.

Receive fewer emails [link removed].

Contact Us. [link removed]

Drug Policy Alliance
131 West 33rd St., 15th Floor New York, NY 10001

Unsubscribe. [link removed]
Screenshot of the email generated on import

Message Analysis